Navigation Links
2008 Ullyot Public Affairs Lecture
Date:11/10/2008

The Ullyot Public Affairs Lecture was established in 1990 to emphasize to the general public the positive role that the chemical and molecular sciences play in our lives. Ullyot Lectures are held annually and are open to the public. Ullyot lecturers are distinguished in their fields, nationally recognized, and able to communicate to a nonscientific audience.

This year's lecture will be given by Bernard Bigot, high commissioner of the French Atomic Energy Commission and a professor of chemistry and physics at the cole Normale Suprieure de Lyon. He is the former auditor for the Higher Studies Institute of the French Defense Ministry.

For four years he was director of the Catalysis Research Institute at the Centre National de la Recherche Scientifique in Lyon-Villeurbanne, and for fifteen years he led the Theoretical Chemistry Laboratory at the cole Normale Suprieure de Lyon.

He has authored 70 scientific publications in the fields of quantum physical chemistry applied to photochemistry, heterogeneous catalysis, reactivity in liquid phase, and nuclear energy.


'/>"/>

Contact: Sarah Reisert
sreisert@chemheritage.org
215-873-8263
Chemical Heritage Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Bridging public and private research on bioinformatics and proteomics
2. Indiana University research at American Public Health Association meeting
3. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
4. Stevens strengthens Dominican Republics Early Warning System for Inundations
5. American Physical Society announces Physics, a new, free, online publication
6. FAS honors Mark D. Levine with 2008 Public Service Award
7. Healthy Minds Across America features 48 public forums on mental health research, Sept. 14
8. Springer bee expert Juergen Tautz wins prize for public communication
9. EMBO recognizes German zoologist for public communication
10. Many US public schools in air pollution danger zone
11. New book tutors future presidents and public on science behind the headlines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... JOLLA, Calif. , Jan. 6, 2017 /PRNewswire/ ... 1 safety studies in healthy volunteers of a ... intended to treat acute pancreatitis. ... is typically a mild disorder, but can be ... organ failure and sepsis, where extended hospital stays, ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... 18, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, will feature data from two ... the 2017 ASCO Gastrointestinal Cancers Symposium, held from January ... Napabucasin is an orally-administered investigational agent designed ... Cancer stem cells (CSCs) possess the property of ...
(Date:1/18/2017)... ... 2017 , ... Whitehouse Labs has furthered its efforts towards ... (AMRI), the scientific staff dedicated to Extractables / Leachables & Impurities has more ... 2017. Extractable & Leachable evaluations have become increasingly more vital to successful product ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, LLC, ... research and genetic testing lab equipment from two different leading institutes. This highly specialized ... regions of the United States. This 1-day online auction will take place on ...
(Date:1/18/2017)... Jan. 18, 2017  Caris Life Sciences, a ... Foundation, the largest private funder of pancreatic cancer ... evaluating the impact of immunotherapy in the treatment ... enrollment services to identify potential trial candidates based ... treating physicians and study investigators. The Lustgarten Foundation ...
Breaking Biology Technology: